Hydrogen + Carbon + Oxygen Compounds (H + C + O)
Found 867,288 compounds containing Hydrogen + Carbon + Oxygen. Page 232 of 17346.
H
Hydrogen
Lightest element, forms water with oxygen
C
Carbon
Basis of organic chemistry
O
Oxygen
Essential for respiration
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C21H17FO | 1-fluoro-2-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 1-fluoro-2-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 304.40 |
| C21H17FO | 1-fluoro-4-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 1-fluoro-4-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 304.40 |
| C18H20F2N2O | N,N-bis(2-fluoroethyl)-4-[(4-methoxyphenyl)iminomethyl]aniline | N-(p-(Bis(2-fluoroethyl)amino)benzylidene)-p-anisidine | 318.40 |
| C20H26O4 | 17-ethynyl-10-hydroperoxy-17-hydroxy-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | NCIOpen2_009978 | 330.40 |
| C21H26N2O | 3-methyl-2-(2-morpholinoethyl)-2-(1-naphthyl)butanenitrile | 1238-65-9 | 322.40 |
| C20H28FNO2 | 4-(7,9-dimethyl-8-oxa-2-azaspiro[4.5]decan-2-yl)-1-(4-fluorophenyl)butan-1-one | BRN 1081731 | 333.40 |
| C22H28BrNO | 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrobromide | 1239-04-9 | 402.40 |
| C22H27NO | 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | PHENAZOCINE | 321.50 |
| C20H30N2O2 | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6-oxa-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,7-dien-17-ol | Furazabol | 330.50 |
| C21H30O3 | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate | Dehydroepiandrosterone acetate | 330.50 |
| C22H28N2O | 3-methyl-2-(2-morpholinoethyl)-2-(1-naphthyl)pentanenitrile | 1241-65-2 | 336.50 |
| C20H29N3O2 | 4-morpholino-2-(2-morpholinoethyl)-2-phenyl-butanenitrile | BUTYRONITRILE, 4-MORPHOLINO-2-(2-MORPHOLINOETHYL)-2-PHENYL- | 343.50 |
| C20H27O4P | 2-ethylhexyl diphenyl phosphate | 2-Ethylhexyl diphenyl phosphate | 362.40 |
| C22H32O3 | [(5S,9S,14S,17S)-2,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | [(5S,9S,14S,17S)-2,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | 344.50 |
| C20H24Cl3N3O | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one;dihydrochloride | 1242-71-3 | 428.80 |
| C20H22ClN3O | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 355.90 |
| C20H29ClN2O4 | 2-[(2-hydroxy-4-oxo-chromene-3-carbonyl)amino]ethyl-diisobutyl-ammonium chloride | 2-[(2-hydroxy-4-oxo-chromene-3-carbonyl)amino]ethyl-diisobutyl-ammonium chloride | 396.90 |
| C20H28N2O4 | N-[2-(diisobutylamino)ethyl]-2-hydroxy-4-oxo-chromene-3-carboxamide | N-[2-(diisobutylamino)ethyl]-2-hydroxy-4-oxo-chromene-3-carboxamide | 360.40 |
| C23H30O4 | 3-[(10R,13R,14S)-14-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1247-04-7 | 370.50 |
| C22H28O5 | (17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | (17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | 372.50 |
| C22H22N2O3 | 5-cyclohexyl-1,3-diphenyl-hexahydropyrimidine-2,4,6-trione | BARBITURIC ACID, 5-CYCLOHEXYL-1,3-DIPHENYL- | 362.40 |
| C20H13N2NaO4S | sodium 2-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulfonate | sodium 2-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulfonate | 400.40 |
| C22H28Cl3N3O | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one;dihydrochloride | 1248-22-2 | 456.80 |
| C22H26ClN3O | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 383.90 |
| C25H46Cl2N2O | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;dihydrochloride | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;dihydrochloride | 461.50 |
| C25H44N2O | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 388.60 |
| C22H29N3O3 | N-[2-[4-[2-(3,4-dimethoxyphenyl)ethyl]piperazin-1-yl]phenyl]acetamide | BRN 0630051 | 383.50 |
| C27H46O2 | (5S)-15-(1,5-dimethylhexyl)-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol | (5S)-15-(1,5-dimethylhexyl)-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol | 402.70 |
| C24H34O5 | [(3S,5R,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] formate | 1250-96-0 | 402.50 |
| C24H31N3O2 | 4-morpholino-2-(2-morpholinoethyl)-2-(1-naphthyl)butanenitrile | alpha,alpha-Bis(2-morpholinoethyl)-1-naphthaleneacetonitrile | 393.50 |
| C27H21FO | 1-benzyloxy-4-[2-(2-fluorophenyl)-1-phenyl-vinyl]benzene | 1-benzyloxy-4-[2-(2-fluorophenyl)-1-phenyl-vinyl]benzene | 380.50 |
| C23H26BrNO4S | 3-(3-bromo-6H-benzo[c][1]benzothiepin-11-ylidene)propyl-dimethyl-ammonium;4-hydroxy-4-oxo-butanoate | 3-(3-bromo-6H-benzo[c][1]benzothiepin-11-ylidene)propyl-dimethyl-ammonium;4-hydroxy-4-oxo-butanoate | 492.40 |
| C25H36N4O9 | 3-[4-(4-acetamidophenyl)piperazin-1-ium-1-yl]propyl-dimethyl-ammonium;bis(4-hydroxy-4-oxo-but-2-enoate) | 3-[4-(4-acetamidophenyl)piperazin-1-ium-1-yl]propyl-dimethyl-ammonium;bis(4-hydroxy-4-oxo-but-2-enoate) | 536.60 |
| C17H28N4O | N-[4-[4-[3-(dimethylamino)propyl]piperazin-1-yl]phenyl]acetamide | PIPERAMIDE | 304.40 |
| C26H38O4 | [(16R)-17-acetyl-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] hexanoate | [(16R)-17-acetyl-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] hexanoate | 414.60 |
| C26H47O3P | didecyl phenyl phosphite | DIDECYL PHENYL PHOSPHITE | 438.60 |
| C24H29FO6 | [2-[(9R,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-16-methylene-3-oxo-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate | SCHEMBL1649450 | 432.50 |
| C28H36O3 | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate | Testosterone phenylpropionate | 420.60 |
| C24H30O7 | [2-(2-formyl-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] acetate | [2-(2-formyl-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] acetate | 430.50 |
| C30H52O | 17-(1,5-dimethylhexyl)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene | Cholesteryl isopropyl ether | 428.70 |
| C25H34O7 | [(3S,5R,10S,12R,13S,14S,17R)-12-formyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] formate | DTXSID40925182 | 446.50 |
| C25H34O7 | [(3S,5R,10S,13R,14S,16S,17R)-16-formyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] formate | 3-Formylgitaloxigenin | 446.50 |
| C29H48O3 | [(3S,5S)-17-(1,5-dimethylhexyl)-10,13-dimethyl-6-oxo-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate | DTXSID60925184 | 444.70 |
| C22H20O13 | 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]anthracene-2-carboxylic acid | Carmine | 492.40 |
| C43H75NO16 | O4-[(2R,3S,4R,6S)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyl-tetrahydropyran-3-yl] O1-ethyl butanedioate | SCHEMBL537373 | 862.10 |
| C18H12BiBr9O3 | bismuthane;tris(2,4,6-tribromophenol) | bismuthane;tris(2,4,6-tribromophenol) | 1204.40 |
| C3H7Na2O6P | disodium;2,3-dihydroxypropyl phosphate | SODIUM GLYCEROPHOSPHATE | 216.04 |
| C8H9NaO3S | sodium 3,4-dimethylbenzenesulfonate | sodium 3,4-dimethylbenzenesulfonate | 208.21 |
| C8H10O3S | 3,4-dimethylbenzenesulfonic acid | 3,4-dimethylbenzene-1-sulfonic acid | 186.23 |
| C9H11HgO2 | acetic acid;p-tolylmercury | acetic acid;p-tolylmercury | 351.77 |